This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Chapter 5: Management of CFRD in children and adolescents

Chapter 5: Management of cystic fibrosis-related diabetes in children and adolescents

Antoinette Moran, Kubendran Pillay, Dorothy Becker, Andrea Gradados, Shihab Hameed and Carlo L. Acerini

Chapter Highlights:

This chapter adds to the 2015 ISPAD guidelines with new information on CFRD pathophysiology, and consideration of new technologies and what we have learned from them.  Ongoing areas of research are discussed including the potential role of CFTR modulator therapy on the natural history of CFRD.

Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal